Clinical Trial Update: Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating MDMA-assisted group therapy for PTSD in veterans has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: PTSD | Phase 2 | Status: WITHDRAWN